Tagged Articles

Risperdal 106 articles

High-dose antipsychotics raise risk of death in children, adolescents

Children and adolescents treated with high doses of antipsychotic medication for conditions not listed on the medication’s label have a significantly higher risk of unexpected death, according to a new study by Vanderbilt University Medical Center researchers. Antipsychotic medication, which includes the brand-name Risperdal, is intended to treat various mental illnesses. For example, Risperdal is used to treat symptoms of schizophrenia, bipolar disorder and irritability in autism in both adults and children. But it is often prescribed off-label to treat behavorial conditions like attention deficit hyperactivity disorder (ADHD) and Tourette’s syndrome. Researchers found that children and adolescents between the ages ... Read More

J&J settles lawsuit alleging Risperdal caused boy to grow breasts

Johnson & Johnson and its unit Janssen Pharmaceuticals have agreed to settle a lawsuit brought by a Mississippi family that claimed the companies’ antipsychotic drug Risperdal caused their son to develop breasts, a disfiguring condition known as gynecomastia, according to Law360. The announcement came just days before the case was slated to go to trial in Pennsylvania state court. The settlement follows a Superior Court ruling in January during which a global order barring punitive damages on gynecomastia claims with Risperdal in the Philadelphia County Court of Common Pleas was upended. Suddenly faced with the potential of  punitive damages, Johnson ... Read More

Two Risperdal cases allowed to seek punitive damages

Two boys can seek punitive damages from Johnson & Johnson’s Janssen Pharmaceuticals on their claims that the company failed to warn them that its antipsychotic Risperdal could cause them to develop female-like breasts, a Pennsylvania judge ruled. The cases were a part of a mass tort program in the Philadelphia County Court of Common Pleas, where about 6,700 cases are pending. In May 2014, Judge New had issued a global order for the Risperdal mass tort program that because of Janssen’s business ties to New Jersey, the company could fall under that state’s law, which protects drug companies against punitive damages ... Read More

Judge urges superior court to uphold $70 million Risperdal verdict

Philadelphia Court of Common Pleas Judge Paula Patrick, who oversaw the 2016 trial that ended with a $70 million award for a child who claimed the antipsychotic drug Risperdal disfigured him, urged the Pennsylvania Superior Court to uphold the verdict saying the multimillion-dollar award was within the jury’s discretion. “Upon consideration of the evidence presented at the trial and the damages sustained by the plaintiffs, this court believes that the jury’s findings should not be disturbed,” Judge Patrick said. Johnson & Johnson subsidiary Janssen Pharmaceuticals appealed the verdict to the Superior Court, arguing that the verdict was excessive. It was ... Read More

Risperdal linked to weight gain, insulin resistance in youths

Children with severe mental disorders who are treated with antipsychotics including Rispedal are at an increased risk of gaining a significant amount of weight in the belly and becoming resistant to insulin, conditions that contribute to early-onset type 2 diabetes, cardiovascular disease and other illnesses associated with premature morbidity and death, according to a new study published in JAMA Psychiatry. Antipsychotics are used to treat adults and children with schizophrenia and other conditions including bipolar disorder and irritability with autism. But they are commonly used off-label to treat nonpsychotic disruptive behaviors, like attention-deficit hyperactivity disorder (ADHD), in children and adolescents. ... Read More

Risperdal case sent back to determine if punitive damages are warranted

The Pennsylvania Superior Court sent a case involving Risperdal side effects back to trial court to decide whether a new trial on punitive damages is warranted. The case was the third bellwether to go to trial from a mass tort program in the Philadelphia County Court of Common Pleas alleging Johnson & Johnson and its subsidiary Janssen Pharmaceuticals failed to warn that its antipsychotic Risperdal could cause adolescent boys to grow female-like breast tissue. The case is that of Nicholas Murray, a Maryland resident, who claimed he took Risperdal for five years as an adolescent, during which time he developed ... Read More

PA judges consider appeal on Risperdal statute of limitations

Johnson & Johnson’s Janssen Pharmaceuticals asked the Pennsylvania Supreme Court to deny an appeal on a recent decision to roll back the clock on when claims of abnormal beast growth in adolescent boys allegedly caused by the antipsychotic Risperdal began to expire. The justices are considering whether to hear an appeal of a ruling by the state’s Supreme Court that puts in jeopardy hundreds of lawsuits among the more than 6,600 currently pending in a mass tort program in Philadelphia County Court of Common Pleas. In November, the court ruled that plaintiffs should have known their breast growth was caused ... Read More

Appeals court rejects J&J’s bid to challenge expert in Risperdal side effects case

A Pennsylvania appeals court rejected Johnson & Johnson’s bid to challenge expert testimony in a trial over claims that its antipsychotic drug Risperdal caused a boy to grow female breasts, which resulted in a $1.75 million verdict against the drug company and its subsidiary Janssen Pharmaceuticals. The verdict was later reduced after a trial judge agreed that the plaintiff was bound by Maryland law, which limits noneconomic damages to $680,000. The three-judge Superior Court panel rejected Janssen’s arguments that plaintiffs expert Dr. Francesco DeLuca had improperly relied on an 8-year-old photograph of plaintiff Nicholas Murry to determine he had gynecomastia, ... Read More

Risperdal lawsuits in PA court nearly doubled in 2017

For the second year in a row, mass tort programs in Philadelphia have reached record highs, with litigation involving the antipsychotic drug Risperdal once again leading the pack. The total inventory of mass tort programs in the city jumped from 196 at the beginning of 2017 to 10,984 by year’s end, representing a 77 percent increase for the Complex Litigation Center’s overall inventory. Pharmaceutical cases saw the most growth in the court, starting the year at 5,601 cases and nearly doubling to 10,395 by Dec. 31, 2017 – a startling 85.5 percent increase. The vast majority of the growth is ... Read More

Order allows punitive damages in PA Risperdal side effects cases

A ruling in Philadelphia Superior Court tossed an order that protected Johnson & Johnson from punitive damages in more than 6,400 cases pending in Philadelphia County over claims that the drug company’s antipsychotic drug Risperdal disfigured adolescent boys. The ruling came from a three-judge panel that was considering an appeal by plaintiff Timothy Strange, who took Risperdal as an adolescent in 2006 to treat symptoms of Tourette’s syndrome. He sued Johnson & Johnson and in December 2015, was awarded $500,000 in compensatory damages. He appealed to the Philadelphia Supreme Court that the law in his home state of Wisconsin favors ... Read More